149 related articles for article (PubMed ID: 37859617)
1. Meta-analysis of multi-modality therapies in sinonasal undifferentiated carcinoma-A timely update.
See ASY; Chu C; Lim ICZY; Tan BKJ; Ang SXQ; Xu S; Teo NWY; Charn TC
Clin Otolaryngol; 2024 Jan; 49(1):29-40. PubMed ID: 37859617
[TBL] [Abstract][Full Text] [Related]
2. Survival Outcomes for Combined Modality Therapy for Sinonasal Undifferentiated Carcinoma.
Kuo P; Manes RP; Schwam ZG; Judson BL
Otolaryngol Head Neck Surg; 2017 Jan; 156(1):132-136. PubMed ID: 27703092
[TBL] [Abstract][Full Text] [Related]
3. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): A case-series, systematic review and meta-analysis.
Morand GB; Anderegg N; Vital D; Ikenberg K; Huber GF; Soyka MB; Egger M; Holzmann D
Oral Oncol; 2017 Dec; 75():28-34. PubMed ID: 29224819
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.
Gamez ME; Lal D; Halyard MY; Wong WW; Vargas C; Ma D; Ko SJ; Foote RL; Patel SH
Head Neck; 2017 Sep; 39(9):1819-1824. PubMed ID: 28561906
[TBL] [Abstract][Full Text] [Related]
5. Sinonasal undifferentiated carcinoma (SNUC): the Alberta experience and literature review.
Xu CC; Dziegielewski PT; McGaw WT; Seikaly H
J Otolaryngol Head Neck Surg; 2013 Jan; 42(1):2. PubMed ID: 23663264
[TBL] [Abstract][Full Text] [Related]
6. Trimodality management of sinonasal undifferentiated carcinoma and review of the literature.
Mourad WF; Hauerstock D; Shourbaji RA; Hu KS; Culliney B; Li Z; Jacobson A; Tran T; Manolidis S; Schantz S; Urken M; Persky M; Harrison LB
Am J Clin Oncol; 2013 Dec; 36(6):584-8. PubMed ID: 22992621
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes and prognostic factors, including human papillomavirus, for sinonasal undifferentiated carcinoma: a retrospective review.
Gray ST; Herr MW; Sethi RK; Diercks G; Lee L; Curry W; Chan A; Clark J; Holbrook EH; Rocco J; Sadow PM; Lin DT
Head Neck; 2015 Mar; 37(3):366-74. PubMed ID: 24421248
[TBL] [Abstract][Full Text] [Related]
8. Sinonasal Undifferentiated Carcinoma.
Abdelmeguid AS; Bell D; Hanna EY
Curr Oncol Rep; 2019 Feb; 21(3):26. PubMed ID: 30806835
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: The importance of differentiation grade in determining treatment strategy.
van der Laan TP; Iepsma R; Witjes MJ; van der Laan BF; Plaat BE; Halmos GB
Oral Oncol; 2016 Dec; 63():1-9. PubMed ID: 27938993
[TBL] [Abstract][Full Text] [Related]
10. Treatment modalities in sinonasal undifferentiated carcinoma: an analysis from the national cancer database.
Khan MN; Konuthula N; Parasher A; Genden EM; Miles BA; Govindaraj S; Iloreta AM
Int Forum Allergy Rhinol; 2017 Feb; 7(2):205-210. PubMed ID: 27717204
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and prognostic factors of sinonasal undifferentiated carcinoma: a multicenter study.
de Bonnecaze G; Verillaud B; Chaltiel L; Fierens S; Chapelier M; Rumeau C; Malard O; Gavid M; Dufour X; Righini C; Uro-Coste E; Rives M; Bach C; Baujat B; Janot F; de Gabory L; Vergez S
Int Forum Allergy Rhinol; 2018 Sep; 8(9):1065-1072. PubMed ID: 29935059
[TBL] [Abstract][Full Text] [Related]
12. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma.
Amit M; Abdelmeguid AS; Watcherporn T; Takahashi H; Tam S; Bell D; Ferrarotto R; Glisson B; Kupferman ME; Roberts DB; Su SY; Raza SM; DeMonte F; Hanna EY
J Clin Oncol; 2019 Feb; 37(6):504-512. PubMed ID: 30615549
[TBL] [Abstract][Full Text] [Related]
13. Improved clinical outcomes with multi-modality therapy for sinonasal undifferentiated carcinoma of the head and neck.
Yoshida E; Aouad R; Fragoso R; Farwell DG; Gandour-Edwards R; Donald PJ; Chen AM
Am J Otolaryngol; 2013; 34(6):658-63. PubMed ID: 23993024
[TBL] [Abstract][Full Text] [Related]
14. Combined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature.
Al-Mamgani A; van Rooij P; Mehilal R; Tans L; Levendag PC
Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):293-9. PubMed ID: 22476411
[TBL] [Abstract][Full Text] [Related]
15. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma.
Takahashi Y; Gleber-Netto FO; Bell D; Roberts D; Xie TX; Abdelmeguid AS; Pickering C; Myers JN; Hanna EY
Oral Oncol; 2019 Oct; 97():56-61. PubMed ID: 31421472
[TBL] [Abstract][Full Text] [Related]
16. Current management of sinonasal undifferentiated carcinoma.
Lopez F; Suárez V; Vivanco B; Suárez C; Llorente JL
Rhinology; 2015 Sep; 53(3):212-20. PubMed ID: 26363162
[TBL] [Abstract][Full Text] [Related]
17. Clinical management of localized undifferentiated sinonasal carcinoma: our experience and review of the literature.
Perri F; Della Vittoria Scarpati G; Ionna F; Longo F; Montano M; Muto P; Ravo V; Giuliano M; Caponigro F
Anticancer Drugs; 2019 Mar; 30(3):308-312. PubMed ID: 30779722
[TBL] [Abstract][Full Text] [Related]
18. Oncologic management of sinonasal undifferentiated carcinoma.
Tyler MA; Holmes B; Patel ZM
Curr Opin Otolaryngol Head Neck Surg; 2019 Feb; 27(1):59-66. PubMed ID: 30507692
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of treatment outcomes for sinonasal undifferentiated carcinoma.
Reiersen DA; Pahilan ME; Devaiah AK
Otolaryngol Head Neck Surg; 2012 Jul; 147(1):7-14. PubMed ID: 22460731
[TBL] [Abstract][Full Text] [Related]
20. Impact of induction chemotherapy and socioeconomics on sinonasal undifferentiated carcinoma survival.
Lehrich BM; Goshtasbi K; Abiri A; Yasaka T; Sahyouni R; Papagiannopoulos P; Tajudeen BA; Kuan EC
Int Forum Allergy Rhinol; 2020 May; 10(5):679-688. PubMed ID: 32104985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
